Epidemiology of symptomatic human rotaviruses in Bangalore and Mysore, India, from 1988 to 1994 as determined by electropherotype, subgroup and serotype analysis
Epidemiology of symptomatic rotaviruses from Bangalore and Mysore in Southern India was investigated. While serotype G3 predominated throughout the 7-year study period from 1988 to 1994 in Bangalore, serotype G1 was more predominant than serotype G3 in Mysore during 1993 and 1994. Serotype G2 strains were either not detected or infrequently observed in both the cities. However, several strains with subgroup I and ‘short’ RNA pattern that exhibited high reactivity with typing MAbs specific for serotype 2 as well as other serotypes were detected throughout the period. Among the nonserotypeable strains from both cities, several exhibited dual subgroup (SGI+II) or subgroup I specificity and ‘long’ RNA pattern indicating their probable animal origin. Notably, a gradual, yet highly significant reduction in rotavirus gastroenteritis, from 45.3% in 1988 to 1.8% during 1994, was observed in Bangalore in stark contrast to the consistently high (about 34%) incidence of asymptomatic infections among neonates by I321-like G10P11 type strains during the same period. Moreover, I321-like asymptomatic strains were not detected in children with diarrhea.
Unable to display preview. Download preview PDF.
- 16.Gerna G, Sarasini A, Coulson BS, Parea M, Torsellini M, Arbustini E, Battaglia M (1988) Comparative sensitivities of solid-phase immune electron microscopy and enzyme-linked immunosorbant assay for serotyping of human rotavirus strains with neutralizing monoclonal antibodies. J Clin Microbiol 26: 1383–1387PubMedGoogle Scholar
- 27.Kapikian AZ, Chanock RM (1990) Rotaviruses. In: Fields BN, Knipe DN, Melnick JL, Chanock RM, Roizman B, Shope RE (eds) Virology, vol 2. Raven Press, New York, pp 1353–1404Google Scholar
- 46.Ushijima H, Mukoyama A, Hasegawa A, Nishimura S, Konishi K, Bosu K (1994) Serotyping of human rotaviruses in the Tokyo area (1990–1993) by enzyme immunoassay with monoclonal antibodies and by reverse transcription and polymerase chain reaction amplification. J Med Virol 44: 162–165PubMedGoogle Scholar